Intercell Reaches Commercial Stage In US: Japanese Encephalitis Vaccine Gets FDA Okay
This article was originally published in The Pink Sheet Daily
Executive Summary
First vaccine approval for Intercell in US brings a new player fully into the vaccine business; Austrian company has key partnerships pending with Merck, Novartis and Sanofi.